Clinical Trials Directory

Trials / Completed

CompletedNCT02520440

INtestinal Failure, multiPle Organ Failure ANd CItrulline Assessment

Clinical Evaluation of Gastro Intestinal Failure, Multiple Organ Failure and Levels of Citrulline in Critical Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The gastrointestinal dysfunction occurs frequently during the intensive care unit (ICU) stay and is associated with a worse prognosis. The gastrointestinal failure (GIF) is diagnosed based on symptoms such as bowel distension, ileus, diarrhea, digestive bleeding, or intestinal ischemia. A GIF score based on has been demonstrated to be correlated with outcome, with higher scores indicating higher risk of death. However, GIF may be occult or clinical signs can go undetected in critically ill patients due to the frequent use of analgesic, sedative or neuromuscular blocking agents, acute neurologic diseases, or delirium. Citrulline is a potential biomarker for small bowel function in critically ill patients with maintained renal function. Normal plasma citrulline levels (12-55 µmol/L) are determined by the balance between gut synthesis and kidney degradation. GIF is involved in the pathogenesis of multiple organ dysfunctions and failures (MOF) through various mechanisms, and it is often associated with high intra-abdominal pressure (IAP). IAP greater than 12 mmHg, may lead to abdominal compartment syndrome (ACS) and MOF, including cardiac, respiratory and kidney failure. Studies have suggested that GIF can be the consequence rather than the cause of MOF. The aim of this study is to investigate if plasma citrulline levels is associated with a clinical diagnosis of GIF, and may predict the development of MOF.

Conditions

Interventions

TypeNameDescription
BIOLOGICALMonitoring of plasmatic levels of CitrullineMeasured plasma amino-acids levels
DEVICEIntra-abdominal pressure monitoringIntra-abdominal Hypertension is defined as an average pressure of the day ≥ 12 mmHg; abdominal compartment syndrome is defined as a sustained (minimally two standardized measurements, performed 1-6 h apart) increase in Intra-abdominal pressure above 20 mmHg with new onset organ failure.
BIOLOGICALMonitoring of plasmatic levels of Arginine and GlutamineMeasured plasma amino-acids levels

Timeline

Start date
2014-09-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2015-08-11
Last updated
2015-08-11

Source: ClinicalTrials.gov record NCT02520440. Inclusion in this directory is not an endorsement.